Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.
- 1 May 1984
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (5) , 1491-1495
- https://doi.org/10.1172/jci111354
Abstract
The cloned complementary DNA for coagulation Factor IX (FIX) detects a frequent restriction fragment length polymorphism (RFLP) in human genomic DNAs digested with the restriction endonuclease Taq I. This genetic marker was used, in parallel with coagulation and immunological assays, to follow the segregation of an abnormal FIX gene in a large Hemophilia B family. Among the six potential female carriers, functional assays showed that four had a high probability, and two a low probability of being carriers. Analysis at the DNA level with the cDNA probe was informative in five of the six cases, and in all these five the diagnosis of carrier state was definitively confirmed. This demonstrates the feasibility of using linkage analysis at the DNA level for the genetic screening of Hemophilia B. This method has the advantages over conventional assays of giving a diagnosis of certainty, and of being applicable to early prenatal diagnosis using biopsies of trophoblast villi. At present, the single known polymorphism associated with the FIX gene restricts the application of linkage analysis to informative cases (40%), but findings of additional RFLPs in this region should improve this figure.Keywords
This publication has 18 references indexed in Scilit:
- CHARACTERISATION AND USE OF AN INTRAGENIC POLYMORPHIC MARKER FOR DETECTION OF CARRIERS OF HAEMOPHILIA B (FACTOR IX DEFICIENCY)The Lancet, 1984
- Prenatal Diagnosis of Sickle-Cell Anemia in the First Trimester of PregnancyNew England Journal of Medicine, 1983
- Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.Journal of Clinical Investigation, 1983
- Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145.Proceedings of the National Academy of Sciences, 1983
- Gene deletions in patients with haemophilia B and anti-factor IX antibodiesNature, 1983
- Isolation and characterization of a cDNA coding for human factor IX.Proceedings of the National Academy of Sciences, 1982
- Improved Detection of the Sickle Mutation by DNA AnalysisNew England Journal of Medicine, 1982
- A Sensitive New Prenatal Test for Sickle-Cell AnemiaNew England Journal of Medicine, 1982
- Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene clusterNature, 1982
- DIRECT GENE ANALYSIS OF CHORIONIC VILLI: A POSSIBLE TECHNIQUE FOR FIRST-TRIMESTER ANTENATAL DIAGNOSIS OF HAEMOGLOBINOPATHIESThe Lancet, 1981